Literature DB >> 31563563

ATXN3 promotes breast cancer metastasis by deubiquitinating KLF4.

Haojing Zou1, Hongyan Chen2, Zhuan Zhou3, Yong Wan4, Zhihua Liu5.   

Abstract

Krüppel-like factor 4 (KLF4) is an important transcription factor implicated in a variety of essential cellular processes. Aberrant KLF4 expression is closely related to tumourigenesis and tumour progression. The rapid turnover of the KLF4 protein indicates an important role for the posttranslational modifications (PTMs) of KLF4. To date, E3 ligases mediating KLF4 ubiquitination have been widely reported, yet the deubiquitinating mechanism of KLF4 remains largely unknown. We screened a library of 65 deubiquitinating enzymes and identified ATXN3 as a deubiquitinating enzyme of KLF4. Subsequent immunoprecipitation assays confirmed that ATXN3 bound to KLF4, mediating the deubiquitination and stabilization of KLF4 protein levels. Furthermore, we demonstrated that ATXN3 promoted breast cancer cell metastasis via KLF4 in vitro and in vivo. Finally, the protein expression analysis of human breast cancer specimens demonstrated that ATXN3 significantly correlated with KLF4. High ATXN3/KLF4 expression was associated with a poor prognosis in breast cancer patients. Collectively, we identified ATXN3 as a novel deubiquitinating enzyme of KLF4, providing a new explanation for breast cancer metastasis, and proposed ATXN3 as a potential target for breast cancer metastasis treatment.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ATXN3; Breast cancer; Deubiquitinating enzyme; KLF4; Metastasis

Mesh:

Substances:

Year:  2019        PMID: 31563563     DOI: 10.1016/j.canlet.2019.09.012

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  15 in total

1.  Deubiquitinase JOSD1 promotes tumor progression via stabilizing Snail in lung adenocarcinoma.

Authors:  Xingjie Ma; Weibo Qi; Fan Yang; Huan Pan
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

2.  Regulation of KLF4 by posttranslational modification circuitry in endocrine resistance.

Authors:  Zhuan Zhou; Xinxin Song; Junlong Jack Chi; David R Gius; Yi Huang; Massimo Cristofanilli; Yong Wan
Journal:  Cell Signal       Date:  2020-02-19       Impact factor: 4.315

3.  Inhibition of USP14 Deubiquitinating Activity as a Potential Therapy for Tumors with p53 Deficiency.

Authors:  Yu-Shui Ma; Xiao-Feng Wang; Yun-Jie Zhang; Pei Luo; Hui-Deng Long; Liu Li; Hui-Qiong Yang; Ru-Ting Xie; Cheng-You Jia; Gai-Xia Lu; Zheng-Yan Chang; Jia-Jia Zhang; Shao-Bo Xue; Zhong-Wei Lv; Fei Yu; Qing Xia; Da Fu
Journal:  Mol Ther Oncolytics       Date:  2020-01-11       Impact factor: 7.200

4.  Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness.

Authors:  Chao Jing; Yuansheng Duan; Mengqian Zhou; Kai Yue; Shanshan Zhuo; Xingchen Li; Dandan Liu; Beibei Ye; Qingchuan Lai; Linqi Li; Xiaofeng Yao; Hui Wei; Wenchao Zhang; Yansheng Wu; Xudong Wang
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

5.  A novel canine reference genome resolves genomic architecture and uncovers transcript complexity.

Authors:  Jennifer R S Meadows; Kerstin Lindblad-Toh; Chao Wang; Ola Wallerman; Maja-Louise Arendt; Elisabeth Sundström; Åsa Karlsson; Jessika Nordin; Suvi Mäkeläinen; Gerli Rosengren Pielberg; Jeanette Hanson; Åsa Ohlsson; Sara Saellström; Henrik Rönnberg; Ingrid Ljungvall; Jens Häggström; Tomas F Bergström; Åke Hedhammar
Journal:  Commun Biol       Date:  2021-02-10

Review 6.  Recent Discoveries on the Involvement of Krüppel-Like Factor 4 in the Most Common Cancer Types.

Authors:  Agnieszka Taracha-Wisniewska; Grzegorz Kotarba; Sebastian Dworkin; Tomasz Wilanowski
Journal:  Int J Mol Sci       Date:  2020-11-22       Impact factor: 5.923

7.  Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells.

Authors:  Hongyan Li; Hong Zhang; Guomin Huang; Zhitong Bing; Duling Xu; Jiadi Liu; Hongtao Luo; Xiaoli An
Journal:  J Exp Clin Cancer Res       Date:  2022-01-24

8.  Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma.

Authors:  Yang Cheng; Kezuo Hou; Yizhe Wang; Yang Chen; Xueying Zheng; Jianfei Qi; Bowen Yang; Shiying Tang; Xu Han; Dongyao Shi; Ximing Wang; Yunpeng Liu; Xuejun Hu; Xiaofang Che
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

9.  Involvement of miR-619-5p in resistance to cisplatin by regulating ATXN3 in oral squamous cell carcinoma.

Authors:  An Song; Yuanyuan Wu; Weiming Chu; Xueming Yang; Zaiou Zhu; Enshi Yan; Wei Zhang; Junbo Zhou; Xu Ding; Jie Liu; Hongxia Zhu; Jinhai Ye; Yunong Wu; Yang Zheng; Xiaomeng Song
Journal:  Int J Biol Sci       Date:  2021-01-01       Impact factor: 6.580

10.  Downregulation of ATXN3 Enhances the Sensitivity to AKT Inhibitors (Perifosine or MK-2206), but Decreases the Sensitivity to Chemotherapeutic Drugs (Etoposide or Cisplatin) in Neuroblastoma Cells.

Authors:  Baocheng Gong; Jinhua Zhang; Zhongyan Hua; Zhihui Liu; Carol J Thiele; Zhijie Li
Journal:  Front Oncol       Date:  2021-07-12       Impact factor: 5.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.